Page last updated: 2024-11-05

tranexamic acid and Psoriasis

tranexamic acid has been researched along with Psoriasis in 1 studies

Tranexamic Acid: Antifibrinolytic hemostatic used in severe hemorrhage.

Psoriasis: A common genetically determined, chronic, inflammatory skin disease characterized by rounded erythematous, dry, scaling patches. The lesions have a predilection for nails, scalp, genitalia, extensor surfaces, and the lumbosacral region. Accelerated epidermopoiesis is considered to be the fundamental pathologic feature in psoriasis.

Research Excerpts

ExcerptRelevanceReference
"Tranexamic acid is a promising future treatment for psoriasis."5.91Tranexamic acid improves psoriasis-like skin inflammation: Evidence from in vivo and in vitro studies. ( Chan, CI; Chen, SJ; Hseu, JH; Hseu, YC; Vadivalagan, C; Wu, PY; Yang, HL; Yen, HR, 2023)
"Tranexamic acid is a promising future treatment for psoriasis."1.91Tranexamic acid improves psoriasis-like skin inflammation: Evidence from in vivo and in vitro studies. ( Chan, CI; Chen, SJ; Hseu, JH; Hseu, YC; Vadivalagan, C; Wu, PY; Yang, HL; Yen, HR, 2023)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Hseu, JH1
Chan, CI1
Vadivalagan, C1
Chen, SJ1
Yen, HR1
Hseu, YC1
Yang, HL1
Wu, PY1

Other Studies

1 other study available for tranexamic acid and Psoriasis

ArticleYear
Tranexamic acid improves psoriasis-like skin inflammation: Evidence from in vivo and in vitro studies.
    Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie, 2023, Volume: 166

    Topics: Animals; Dermatitis; Disease Models, Animal; Humans; Imiquimod; Inflammasomes; Inflammation; Interle

2023